Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Francois Nader, M.D., has been appointed to the Company’s Board of Directors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE